LCTX compared with STAA: revenue, margins and what each company keeps, and the suppliers and customers both name

LCTXLineage Cell Therapeutics, Inc.

Mkt capRevenueRevenue

STAAStaar Surgical Co

Mkt capRevenueRevenue

Compare

LCTXLineage Cell Therapeutics, Inc.

STAAStaar Surgical Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LCTX 12

—Cell Cure Neurosciences Ltd. (CCN)unlistedsupplier

—Hadasitunlistedsupplier

—Cancer Research Technology (CRT)unlistedsupplier

—Israel Innovation Authority (IIA)unlistedsupplier

8 more · LCTX chain ›

Shared 0

No disclosed counterparties: STAA.

Only STAA 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LCTXLineage Cell Therapeutics, Inc.

1.01▼−2.30%· post 1.01

Mkt cap$252.9MRevenue$1MQ2 FY26Revenue$15MFY25

STAAStaar Surgical Co

24.56▼−2.70%· post 24.60

ClosedOct 30 '26

Mkt cap$1.2BRevenue$94MQ2 FY26Revenue$239MFY25

Compare

ClosedOct 30 '26

LCTXLineage Cell Therapeutics, Inc.

STAAStaar Surgical Co

1.01▼−2.30%post 1.01

Price

24.56▼−2.70%post 24.60

$252.9M

Mkt cap

$1.2B

Q2 FY26$1M

Revenue

$94MQ2 FY26

FY25$15M

Revenue

$239MFY25

LCTX1.01▼−2.30%vsSTAA24.56▼−2.70%ClosedOct 30 '26